• 99mTc-DPR-SSS-BBN for diagnosis of human cancers [abstract] 

    Heinzke, Laura; Retzloff, Lauren Brooke, 1980-; Lane, Stephanie R., 1982-; Prasanphanich, Adam; Sieckman, Gary; Rold, Tammy L.; Hoffman, Timothy Joseph, 1958-; Smith, Charles J. (Charles Jeffrey), 1969- (University of Missouri--Columbia. Office of Undergraduate Research, 2008)
    Receptor-specific, radiolabeled peptides have become increasingly popular as targeting vectors for the development of new diagnostic radiopharmaceuticals. The over-expression of certain receptors such as the gastrin releasing ...
  • Evaluation of a new series of copper-64-nota-bombesin targeted radiopharmecuticals with PET imaging potential [abstract] 

    Prasanphanich, Adam; Nanda, Prasant Kumar; Rold, Tammy L.; Hoffman, Timothy Joseph, 1958-; Smith, Charles J. (Charles Jeffrey), 1969- (University of Missouri--Columbia. Office of Undergraduate Research, 2007)
    Tissue-specific radiopharmaceuticals having promise as diagnostic and therapeutic targeting vectors for human cancers is of significant interest. In recent years, our group and many others have focused upon design and ...
  • In vitro/in vivo assessment of novel 99mTc-bombesin conjugates in human cancer tissue [abstract] 

    Heinzke, Laura; Prasanphanich, Adam; Lane, Stephanie R., 1982-; Retzloff, Lauren Brooke, 1980-; Rold, Tammy L.; Sieckman, Gary; Hoffman, Timothy Joseph, 1958-; Smith, Charles J. (Charles Jeffrey), 1969- (University of Missouri--Columbia. Office of Undergraduate Research, 2007)
    Receptor-specific, radiolabeled peptides are becoming increasingly popular as targeting vectors for the development of new diagnostic radiopharmaceuticals. The over-expression of certain receptors such as the gastrin ...
  • Synthesis and characterization of Bombesin derivatives with potential applications as nuclear medicine imaging/therapeutic agents [abstract] 

    Prasanphanich, Adam; Smith, Charles J. (Charles Jeffrey), 1969- (University of Missouri--Columbia. Office of Undergraduate Research, 2006)
    The use of tissue specific radiopharmaceuticals presents great promise for diagnostic and therapeutic applications in a number of human cancers. Gastrin-releasing peptide (GRP) receptors are known to be over-expressed on ...